Clinical Trial Update: Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 [Phase 4]

View source ↗

Summary

Phase 4 update reporting long-term safety follow-up data for subjects with giant cell tumor of bone treated with denosumab (Study 20062004); results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Bone

Drugs mentioned

• Prolia (denosumab)
• Xgeva (denosumab)

Snippet

Sponsor: Amgen | Conditions: Giant Cell Tumor of Bone | Phase 4 | Status: COMPLETED | Results posted: 2024-05-20